OxyContin maker stops promoting opioids, cuts sales staff

(Reuters) – OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers.

Leave a Reply

Your email address will not be published. Required fields are marked *